Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
NOVARTIS PHARMA AG | 0001030617 | Jun-15-2022 | 10 percent owner |
NOVARTIS AG | 0001114448 | Jun-15-2022 | 10 percent owner |
Brown Melinda | 0001682988 | May-26-2022 | director |
Wadsworth Samuel C. | 0001653056 | Nov-08-2021 | director |
Pire Shari Lisa | 0001892150 | Nov-08-2021 | director |
Amoroso Michael | 0001830874 | Oct-15-2021 | director, officer: President and CEO |
List Alan | 0001858530 | Apr-26-2021 | officer: Chief Medical Officer |
Frankel Stanley | 0001855726 | Apr-12-2021 | director |
Kelly John Alexander | 0001590030 | Jan-01-2021 | officer: Interim CFO |
Barton Shane | 0001836297 | Jan-01-2021 | officer: VP & Corporate Controller |
Germano Geno J | 0001424383 | Mar-10-2020 | director |
Buehler Kevin | 0001792722 | Nov-08-2019 | director |
Heery Christopher | 0001789632 | Sep-30-2019 | officer: Chief Medical Officer |
Scimeca Dario | 0001779581 | Jun-10-2019 | officer: General Counsel |
FMR LLC | 0000315066 | Mar-27-2019 | 10 percent owner, other: See Remark 1 |
GOODMAN COREY S | 0001278411 | Mar-27-2019 | 10 percent owner |
Adelman Robert J | 0001329161 | Mar-27-2019 | director, 10 percent owner |
Sharp Shalini | 0001377202 | Mar-27-2019 | director |
Schinazi Raymond F | 0001397607 | Mar-27-2019 | director |
venBio Global Strategic Fund, L.P. | 0001504130 | Mar-27-2019 | director, 10 percent owner |
JANTZ DEREK | 0001769828 | Mar-27-2019 | director, 10 percent owner, officer: Chief Scientific Officer |
KANE MATTHEW R. | 0001769887 | Mar-27-2019 | director, 10 percent owner, officer: President and CEO |
ANSARI ABID | 0001770149 | Mar-27-2019 | officer: Chief Financial Officer |
SMITH J. JEFFERSON | 0001770169 | Mar-27-2019 | 10 percent owner |
KHAZI FAYAZ | 0001770314 | Mar-27-2019 | officer: CEO of Elo Life Systems |
THOMSON DAVID S. | 0001770315 | Mar-27-2019 | officer: Chief Development Officer |
venBio Global Strategic GP, L.P. | 0001770834 | Mar-27-2019 | 10 percent owner |
venBio Global Strategic GP, Ltd. | 0001770835 | Mar-27-2019 | 10 percent owner |
YAO TONY DUNG LING | 0001771680 | Mar-27-2019 | director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by PRECISION BIOSCIENCES INC
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
8-K | Document | Current report filing Acc-no: 0000950170-24-105706 (34 Act) Size: KB |
Sep-12-2024 | 241293935 |
8-K | Document | Current report filing Acc-no: 0000950170-24-102561 (34 Act) Size: KB |
Sep-03-2024 | 241272047 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-100021 ( Act) Size: 0 KB |
Aug-23-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-100020 ( Act) Size: 0 KB |
Aug-23-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-100019 ( Act) Size: 0 KB |
Aug-23-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-100018 ( Act) Size: 0 KB |
Aug-23-2024 | |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-24-088951 (34 Act) Size: KB |
Aug-01-2024 | 241164282 |
8-K | Document | Current report filing Acc-no: 0000950170-24-088950 (34 Act) Size: KB |
Aug-01-2024 | 241164279 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0000950170-24-079276 (33 Act) Size: KB |
Jul-01-2024 | 241088215 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-072052 ( Act) Size: 0 KB |
Jun-11-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-072050 ( Act) Size: 0 KB |
Jun-11-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-072049 ( Act) Size: 0 KB |
Jun-11-2024 | |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-004313 (33 Act) Size: 0 KB |
Jun-10-2024 | 241032453 |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-004311 (33 Act) Size: 0 KB |
Jun-10-2024 | 241032435 |
8-K | Document | Current report filing Acc-no: 0000950170-24-071082 (34 Act) Size: KB |
Jun-10-2024 | 241031497 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-069942 ( Act) Size: 0 KB |
Jun-06-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-069941 ( Act) Size: 0 KB |
Jun-06-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-069940 ( Act) Size: 0 KB |
Jun-06-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-069938 ( Act) Size: 0 KB |
Jun-06-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-069936 ( Act) Size: 0 KB |
Jun-06-2024 |
Recent 20 filings. View all PRECISION BIOSCIENCES INC filings
Thanks I look forward to using the product to improve my skin tone
Huge help thank you for your help .. y'all make it so much easier
young lad who new his job ansered questions and new what was best for me.
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by